AZ HB2380

Expands oral prescription pharmaceuticals that optometrists may prescribe to include agents for treating angle-closure glaucoma and carbonic anhydrase inhibitors.

Allows optometrists to prescribe oral steroids in amounts not exceeding a single 7-day course of therapy.

Adds fluroquinolones and antivirals to the list of anti-infective agents optometrists may prescribe, while maintaining existing consultation and referral requirements if conditions do not improve within specified timeframes.

Clarifies that optometrists cannot prescribe oral pharmaceuticals or controlled substances to persons under six years of age.

Permits optometrists to prescribe schedule III controlled substances only if they are analgesics that were reclassified from schedule III to schedule II after January 1, 2014.